Mississauga, Ontario – GenomeArc is proud to announce the release of GenomeArc Horizon Version 2.0, a transformative update to its groundbreaking multi-OMICs platform that enhances genetic diagnosis. This latest version introduces cutting-edge features designed to accelerate diagnostic workflows, deepen genomic insights, and enhance clinical decision-making.

At the core of Horizon 2.0 lies ACMG Ultra-Speed Diagnosis, which significantly reduces the time required to assess and classify genetic variants. Powered by Horizon Intelligence, the platform now offers dynamic, prompt-driven variant search capabilities, streamlining reporting, data exploration and variant prioritization for clinicians and researchers.

A key advancement in Horizon 2.0 is its expanded multi-OMICs integration, allowing seamless incorporation of gene level proteomics mass-spec expression and single-cell transcriptomics data alongside whole genome analysis. This integration provides unparalleled insights into pathogenic genes by leveraging a multi-layered, systems biology approach.

In oncology, Horizon 2.0 introduces tools to identify driver genes through cancer-germline pair analysis and can now predict cancer types from liquid biopsy variants with remarkable accuracy. These enhancements offer new pathways for early detection and targeted treatment strategies.

Furthermore, pharmacogenomics insights have been significantly enriched through GenomeArc’s proprietary database, providing clinicians with more precise guidance on drug efficacy and safety, ultimately paving the way for personalized therapies.

“Horizon 2.0 represents a major leap forward in our mission to empower clinicians and researchers with AI-driven, data-rich insights that translate into enhanced diagnosis and genomic discovery,” said Dr. Mohammed U Dafil, Founder and CEO of GenomeArc. “By expanding multi-OMICs capabilities and enhancing our oncology (liquid biopsy) and pharmacogenomics tools/databases in one comprehensive platform, we are pushing the boundaries of what precision medicine can achieve”, he added.

GenomeArc Horizon 2.0 is now available to existing and new clients. For more information or to request a demo, please visit https://genomearc.com/horizon.

GenomeArc Communications Team

Email: info@genomearc.com